REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS

por WILLIAMS, STEPHANIE N, WALO JR, RICHARD, LATTANZIO, NATALIA, DAWKINS, KEVIN, K ABDELAL, QASSEM, HAMAD, KAREN, WIESE-ROMETSCH, WILHELMINE
Publicado 2022